Ethos Discovery acts as an incubator for Scientific Innovations addressing unmet diagnostic and therapeutic needs.
Ethos Discovery is a stand-alone not for profit created to fulfill unmet needs that hold the potential to improve outcomes for veterinary and human health care patients. It is our hope that Ethos Discovery research and clinical studies will pave the way for innovations that provide improved diagnostic and treatment options that lead to a cure for complex medical conditions such as cancer. Our scientific studies are aligned with the innovation platforms of a variety of academic and research institutions. We embrace the established scientific model of comparative oncology, and evaluate novel diagnostics and therapeutic treatments in pets with naturally-occurring medical conditions.
About Us
Donate
Help change the future for pets (and humans) with complex medical problems. 100% of your donation will go towards supporting our research.
Learn more & Donate Today
Our Programs
Our scientific strategy focuses on identifying areas of unmet need through the optics of clinical teams within Ethos Veterinary Health. These hospitals provide us with access to families with pets with naturally occurring disease.
Our Studies
Study Guides
When you enroll your pet in an Ethos Discovery study your pet continues to receive therapy for his or her condition under the care of your existing specialist. More information and relevant details are available for study participants.
What to Expect
Our Team
The leadership team at Ethos Discovery aligns the identified, unmet needs of clinical veterinary teams with academic and institutional nonprofit and commercial collaborators around the world.
Leadership Team
Ethos Hospitals
Ethos is a veterinary health organization with hospitals across the U.S. providing advanced medical care for pets. This real-time collaboration with Ethos clinicians allows us to develop new diagnostic and therapeutic solutions we can implement and share.
Ambassador ProgramLatest Posts
View All-
Early Intervention Strategies for Necrotizing Meningoencephalitis in Pugs – Are Stem Cells the Future?
November 12, 2024An ongoing Ethos Discovery clinical trial titled Stem Cell Therapy for Early Encephalitis in Pugs (STEEP) has explored the use of mesenchymal stem cells (MSCs) as a potential treatment for NME. Stem cells have been shown to possess immunomodulatory and regenerative properties, making them a promising option for treating neuroinflammatory diseases like NME.
Read Article -
Hemoperitoneum in Dogs: New Hope for Canine Hemangiosarcoma Treatment
July 3, 2024Recent findings from prospective trials by Ethos Discovery offer new hope and a brighter outlook for dogs with Hemoperitoneum.
Read Article -
Sepsis in Dogs: A Step Towards Better Diagnostics & Treatments
May 15, 2024Ethos Discovery aims to uncover potential biomarkers and therapeutic targets that could revolutionize the way we diagnose and treat sepsis in dogs.
Read Article
Latest News
CHOU2 PHARMA Partners with Ethos Discovery to Study Potential New Therapy for Canine Idiopathic Epilepsy
January 30, 2025Narberth, PA, January 27, 2025 /PRNewswire/ — Chou2 Pharma LLC, a company focused on advancing the therapeutic use of cannabinoid molecules in veterinary medicine, is pleased to announce that the company has initiated a new study in partnership with Ethos Discovery to evaluate pharmacokinetics of a potential new proprietary animal drug formulation for treating idiopathic
Read Article